Follicular thyroid carcinoma metastasis to the facial skeleton: a systematic review

BMC Cancer

Case Report

Raja Sawhney¹  Varun V. Varadarajan¹  Peter T. Dziegielewski²  Vatsal Patel³  Elizabeth K. Pace⁴  Robert J. Amdur⁵ 

[1] Department of Otolaryngology (ENT), University of Florida, 32610, Gainesville, FL, USA;Department of Otolaryngology (ENT), University of Florida, 32610, Gainesville, FL, USA;University of Florida Health Cancer Center, Gainesville, FL, USA;Department of Pathology, University of Florida, Gainesville, FL, USA;University of Florida College of Medicine, Gainesville, FL, USA;University of Florida Health Cancer Center, Gainesville, FL, USA;Department of Radiology, University of Florida, Gainesville, FL, USA;

关键词: Follicular thyroid carcinoma;    Head and neck surgery;    Endocrine surgery;    Thyroid neoplasm;   

DOI  :  10.1186/s12885-017-3199-3

 received in 2016-11-30, accepted in 2017-03-15,  发布年份 2017

来源: Springer

【 摘 要 】

BackgroundFollicular thyroid carcinoma (FTC) metastasis to the facial skeleton is exceedingly rare. A case of FTC metastasizing to the mandible is presented and a systematic review of the literature describing thyroid metastasis to the facial skeleton is performed.Case presentationA 73-year-old female presented with metastatic FTC to the mandible and underwent total thyroidectomy, segmental mandibulectomy, bone impacted fibular free flap reconstruction, and adjuvant radioactive iodine treatment. The PubMed database was searched for literature describing thyroid cancer with facial skeleton metastasis using the key words “thyroid,” “cancer,” “carcinoma,” “metastasis,” and “malignancy” with “oral cavity,” “maxilla,” “mandible,” “sinus,” “paranasal,” and “orbit.” Reports that only involved the soft tissues were excluded. Systematic review revealed 59 cases of well-differentiated thyroid cancer with facial skeleton metastasis: 35 mandibular metastases (21 = FTC), 6 maxilla metastases (2 = FTC), 9 orbital metastases (4 = FTC), and 11 paranasal sinus metastases (7 = FTC). Treatment included surgery, RAI, external beam radiotherapy (XRT), or a combination of these modalities. The one, two, and five-year survival rates were 100%, 79%, and 16%, respectively.ConclusionFacial skeleton metastasis of FTC is a rare clinical challenge. Optimal treatment appears to include total thyroidectomy and resection of involved structures with or without adjuvant treatment.

【 授权许可】

CC BY   
© The Author(s). 2017